scholarly article | Q13442814 |
P2093 | author name string | C Chabbert | |
C Travo | |||
G Desmadryl | |||
E Wersinger | |||
A Saleur | |||
A Broussy | |||
A Brugeaud | |||
J Dyhrfjeld-Johnsen | |||
S Gaboyard-Niay | |||
P2860 | cites work | Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes | Q24290193 |
Neuropharmacology of vestibular system disorders | Q24624927 | ||
Which medication do I need to manage dizzy patients? | Q28300141 | ||
A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties | Q28571371 | ||
cDNA cloning and characterization of porcine histamine H4 receptor | Q31059304 | ||
The physiology of brain histamine. | Q31875011 | ||
Cloning and pharmacological characterization of a fourth histamine receptor (H(4)) expressed in bone marrow | Q31941917 | ||
Cloning, expression, and pharmacological characterization of a novel human histamine receptor. | Q31941941 | ||
Calyx and dimorphic neurons of mouse Scarpa's ganglion express histamine H3 receptors | Q33475923 | ||
Animal research: reporting in vivo experiments: the ARRIVE guidelines | Q34116755 | ||
Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells | Q34182519 | ||
Ion channels set spike timing regularity of mammalian vestibular afferent neurons | Q34212876 | ||
Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist | Q34425247 | ||
Histamine and betahistine in the treatment of vertigo: elucidation of mechanisms of action | Q34432126 | ||
Coupling of histamine H3 receptors to neuronal Na+/H+ exchange: a novel protective mechanism in myocardial ischemia | Q34500237 | ||
Highly potent and selective ligands for histamine H3-receptors | Q34661299 | ||
Control of hair cell excitability by vestibular primary sensory neurons | Q36015278 | ||
The histamine H(4) receptor: a novel modulator of inflammatory and immune disorders | Q36726806 | ||
Betahistine in the treatment of Ménière's disease. | Q37126812 | ||
A new generation of anti-histamines: Histamine H4 receptor antagonists on their way to the clinic | Q37593489 | ||
Low-voltage-activated potassium channels underlie the regulation of intrinsic firing properties of rat vestibular ganglion cells | Q39097136 | ||
Guidelines for reporting experiments involving animals: the ARRIVE guidelines | Q39512979 | ||
Agonist-biased signaling at the histamine H4 receptor: JNJ7777120 recruits β-arrestin without activating G proteins. | Q39623360 | ||
Molecular determinants of ligand binding to H4R species variants | Q39747626 | ||
Histamine H(4) receptors regulate ACTH release in AtT-20 cells. | Q39987892 | ||
Monitoring agonist-promoted conformational changes of beta-arrestin in living cells by intramolecular BRET. | Q40110003 | ||
Preparation and biological evaluation of indole, benzimidazole, and thienopyrrole piperazine carboxamides: potent human histamine h(4) antagonists | Q40338159 | ||
Synthesis and structure-activity relationships of indole and benzimidazole piperazines as histamine H(4) receptor antagonists. | Q40509880 | ||
Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation | Q40558411 | ||
The first potent and selective non-imidazole human histamine H4 receptor antagonists | Q40638111 | ||
The histamine H4 receptor is functionally expressed on neurons in the mammalian CNS | Q41420104 | ||
Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives | Q41888634 | ||
Interactions of histamine H1-receptor agonists and antagonists with the human histamine H4-receptor | Q42024153 | ||
Effects of betahistine at histamine H3 receptors: mixed inverse agonism/agonism in vitro and partial inverse agonism in vivo | Q42472544 | ||
Dose- and duration-dependent effects of betahistine dihydrochloride treatment on histamine turnover in the cat. | Q42485327 | ||
Betahistine produces post-synaptic inhibition of the excitability of the primary afferent neurons in the vestibular endorgans | Q42511933 | ||
Histamine (H3) receptors modulate the excitatory amino acid receptor response of the vestibular afferents | Q42674170 | ||
The vestibular nerve of the chinchilla. II. Relation between afferent response properties and peripheral innervation patterns in the semicircular canals | Q43471697 | ||
Localization of histamine H4 receptors in the central nervous system of human and rat. | Q46153368 | ||
A national survey amongst UK otolaryngologists regarding the treatment of Ménière's disease | Q46436639 | ||
Actions of betahistine at histamine receptors in the brain | Q48495593 | ||
Conformational changes in the M2 muscarinic receptor induced by membrane voltage and agonist binding | Q48682233 | ||
The effect of Serc (betahistine hydrochloride) on the circulation of the inner ear in experimental animals. | Q54492663 | ||
3,3'-Iminodipropionitrile induces neurofilament accumulations in the perikarya of rat vestibular ganglion neurons | Q71341150 | ||
The behavioral syndrome caused by 3,3'-iminodipropionitrile and related nitriles in the rat is associated with degeneration of the vestibular sensory hair cells | Q72628405 | ||
Comparison of behavioral, vestibular, and axonal effects of subchronic IDPN in the rat | Q73308230 | ||
Effects of betahistine on vestibular receptors of the frog | Q77193890 | ||
Histamine excites neurones in the human submucous plexus through activation of H1, H2, H3 and H4 receptors | Q80604568 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 905-916 | |
P577 | publication date | 2012-10-01 | |
P1433 | published in | British Journal of Pharmacology | Q919631 |
P1476 | title | Histamine H4 receptor antagonists as potent modulators of mammalian vestibular primary neuron excitability | |
P478 | volume | 167 |
Q48491449 | A search for functional histamine H4 receptors in the human, guinea pig and mouse brain |
Q46489053 | Adjustment of the dynamic weight distribution as a sensitive parameter for diagnosis of postural alteration in a rodent model of vestibular deficit |
Q30371381 | Correlation between afferent rearrangements and behavioral deficits after local excitotoxic insult in the mammalian vestibule: a rat model of vertigo symptoms. |
Q48134020 | Effect of M-current modulation on mammalian vestibular responses to transient head motion. |
Q37124388 | Evidence for a Role of Orexin/Hypocretin System in Vestibular Lesion-Induced Locomotor Abnormalities in Rats |
Q34025192 | Histamine H4 receptor as a new therapeutic target for choroidal neovascularization in age-related macular degeneration |
Q64287379 | Histamine H4 receptor gene polymorphisms: a potential contributor to Meniere disease |
Q38128902 | Histamine pharmacology: four years on. |
Q26827568 | International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors |
Q53184123 | Localization of histamine (H1, H2, H3 and H4) receptors in mouse inner ear. |
Q38603260 | Motion Sickness: Current Knowledge and Recent Advance |
Q42367598 | Neuropharmacological Targets for Drug Action in Vestibular Sensory Pathways. |
Q38248956 | Novel histamine H4 receptor ligands and their potential therapeutic applications: an update. |
Q58562898 | To scratch an itch: Establishing a mouse model to determine active brain areas involved in acute histaminergic itch |
Q36175380 | Transient alteration of the vestibular calyceal junction and synapse in response to chronic ototoxic insult in rats |
Search more.